Curanex Pharmaceuticals Inc
CURX
$4.02
$0.020.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 137.50K | 63.90K | 102.10K | 80.20K | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 137.50K | 63.90K | 102.10K | 80.20K | |
| Operating Income | -137.50K | -63.90K | -102.10K | -80.20K | |
| Income Before Tax | -137.60K | -137.20K | -99.90K | -80.20K | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -137.60K | -137.20K | -99.90K | -80.20K | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -137.60K | -137.20K | -99.90K | -80.20K | |
| EBIT | -137.50K | -63.90K | -102.10K | -80.20K | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | -0.01 | -0.01 | 0.00 | -0.13 | |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.08 | |
| EPS Diluted | -0.01 | -0.01 | 0.00 | -0.13 | |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.08 | |
| Average Basic Shares Outstanding | 24.00M | 24.08M | 24.16M | 600.00K | |
| Average Diluted Shares Outstanding | 24.00M | 24.08M | 24.16M | 600.00K | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |